Personalised
Solutions

by Edwards Lifesciences–with the broadest portfolio of therapies

See Our TMTT Portfolio

Personalised
Touch

by you, the physician–to deliver optimal care for the most patients

Access Resources

In collaboration with cardiologists like you, Edwards Transcatheter Mitral and Tricuspid Therapies (TMTT) group is making a meaningful mark on the lives of patients with mitral and tricuspid regurgitation.

Personalised
Solutions

by Edwards Lifesciences–with the broadest portfolio of therapies

See Our TMTT Portfolio

Personalised
Touch

by you, the physician–to deliver optimal care for the most patients

Access Resources

Stay up to date with our personalised solutions, sent directly to your inbox

Sign up now and get the latest information, news, and events on mitral and tricuspid therapies by Edwards.

Thank You

For professional use

For professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).

Edwards devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.

Cardioband Systems are manufactured by Valtech Cardio Ltd. for Edwards Lifesciences.

Edwards, Edwards Lifesciences, the stylized E logo, Cardioband, PASCAL, PASCAL Ace, Valtech, and Valtech Cardio are trademarks or service marks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners.

© 2021 Edwards Lifesciences Corporation. All rights reserved. PPEU-0591 v1.0

Edwards Lifesciences • Route de l’Etraz 70, 1260 Nyon, Switzerland • edwards.com